Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Eur Surg Res ; 43(4): 348-53, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19776591

RESUMEN

BACKGROUND/AIMS: The principal aim of conservation is to maintain the viability of grafts. This requires the addition of a cellular protector allowing better conservation of the graft. The aim of this work is to evaluate the effect of trimetazidine (TMZ) addition to Wistar rat livers conserved in Krebs-Henseleit solution, compared to the livers preserved only in Krebs-Henseleit solution (24 h at 4 degrees C). METHODS: 40 Wistar female rats divided into 5 groups were used: the first group consists of nonpreserved livers, the second consists of livers preserved only in the Krebs-Henseleit solution, and the other 3 groups consist of livers preserved in Krebs solution with different concentrations of TMZ added (16.5, 49.5 and 165 microg/ml). RESULTS: The obtained results show an improvement in the state of the liver in the presence of a high concentration of TMZ, which approaches normal physiological conditions. We note a clear diminution of transaminase activities, as well as an amelioration in metabolic capacities of the liver if the mitochondrial esterase pathway is supported in Wistar rats by a reduction of histological injuries. CONCLUSION: A TMZ concentration of 165 microg/ml clearly restored the metabolic capacities of the liver. Indeed, TMZ limited the appearance of necrotic areas and almost suppressed apoptotic cells.


Asunto(s)
Isquemia Fría/métodos , Hígado , Preservación de Órganos/métodos , Animales , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Femenino , Glucosa , Técnicas In Vitro , Hígado/irrigación sanguínea , Hígado/efectos de los fármacos , Hígado/lesiones , Hígado/metabolismo , Trasplante de Hígado , Espectroscopía de Resonancia Magnética , Soluciones Preservantes de Órganos , Ratas , Ratas Wistar , Daño por Reperfusión/metabolismo , Daño por Reperfusión/patología , Daño por Reperfusión/prevención & control , Trimetazidina/administración & dosificación , Trometamina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA